The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis
Open accessAbstract
Epithelial-mesenchymal (EMT) and mesenchymal-epithelial (MET) transitions occur in the development of human tumorigenesis and are part of the natural history of the process to adapt to the changing microenvironment. In this setting, the miR-200 family is recognized as a master regulator of the epithelial phenotype by targeting ZEB1 and ZEB2, two important transcriptional repressors of the cell adherence (E-cadherin) and polarity (CRB3 and LGL2) genes. Recently, the putative DNA methylation associated inactivation of various miR-200 members has been described in cancer. Herein, we show that the miR-200ba429 and miR-200c141 transcripts undergo a dynamic epigenetic regulation linked to EMT or MET phenotypes in tumor progression. The 5'-CpG islands of both miR-200 loci were found unmethylated and coupled to the expression of the corresponding miRNAs in human cancer cell lines with epithelial features, such as low levels of ZEB1/ZEB2 and high expression of E-cadherin, CRB3 and LGL2, while CpG island hypermethylation-associated silencing was observed in transformed cells with mesenchymal characteristics. The recovery of miR-200ba429 and miR-200c141 expression by stable transfection in the hypermethylated cells restored the epithelial markers and inhibited migration in cell culture and tumoral growth and metastasis formation in nude mice. We also discovered, using both cell culture and animal models, that the miR-200 epigenetic silencing is not an static and fixed process but it can be shifted to hypermethylated or unmethylated 5'-CpG island status corresponding to the EMT and MET phenotypes, respectively. In fact, careful laser microdissection in human primary colorectal tumorigenesis unveiled that in normal colon mucosa crypts (epithelia) and stroma (mesenchyma) already are unmethylated and methylated at these loci, respectively; and that the colorectal tumors undergo selective miR-200 hypermethylation of their epithelial component. These findings indicate that the epigenetic silencing plasticity of the miR-200 family contributes to the evolving and adapting phenotypes of human tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Real-time quantification of microRNAs by stem-loop RT-PCR
Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,952
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Esteller, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072067 · Cited by 3,662
Self-citationTransitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121
Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
Yang, J., & Weinberg, R. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,012
TGF-β-induced epithelial to mesenchymal transition
Xu, J., Lamouille, S., & Derynck, R. (2009) · Cell Research · doi:10.1038/cr.2009.5 · Cited by 2,804
Biomarkers for epithelial-mesenchymal transitions
Zeisberg, M., & Neilson, E. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36183 · Cited by 2,299 · cited 2×
“…cellular detachment from the primary tumor, invasion of adjacent stroma, entry into the systemic circulation and extravasation (Thiery, 2002; Yang and Weinberg, 2008; Acloque et al., 2009; Kalluri and Weinberg, 2009; Polyak and Weinberg, 2009; Thiery et al., 2009; Zeisberg and Neilson, 2009).”
BackgroundPark, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
Edwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002
Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S., & Brabletz, T. (2008) · EMBO reports · doi:10.1038/embor.2008.74 · Cited by 1,722
Korpal, M., Lee, E. S., Hu, G., & Kang, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800074200 · Cited by 1,645
TGF-β and epithelial-to-mesenchymal transitions
Zavadil, J., & Böttinger, E. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208927 · Cited by 1,578
Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease
Acloque, H., Adams, M. S., Fishwick, K., Bronner-Fraser, M., & Nieto, M. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38019 · Cited by 1,370
Saito, Y., Liang, G., Egger, G., Friedman, J. M., Chuang, J. C., Coetzee, G. A., & Jones, P. A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.020 · Cited by 1,335
Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression
Hugo, H., Ackland, M. L., Blick, T., Lawrence, M. G., Clements, J. A., Williams, E. D., & Thompson, E. W. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21223 · Cited by 1,091
A microRNA DNA methylation signature for human cancer metastasis
Lujambio, A., Calin, G. A., Villanueva, A., Ropero, S., Sánchez-Céspedes, M., Blanco, D., Montuenga, L. M., Rossi, S., Nicoloso, M. S., Faller, W. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803055105 · Cited by 1,078
Self-citationBracken, C. P., Gregory, P. A., Kolesnikoff, N., Bert, A. G., Wang, J., Shannon, M. F., & Goodall, G. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1942 · Cited by 1,060
Brabletz, T., Jung, A., Reu, S., Porzner, M., Hlubek, F., Kunz-Schughart, L. A., Knuechel, R., & Kirchner, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171610498 · Cited by 1,049
Genetic Unmasking of an Epigenetically Silenced microRNA in Human Cancer Cells
Lujambio, A., Ropero, S., Ballestar, E., Fraga, M. F., Cerrato, C., Setién, F., Casado, S., Suarez-Gauthier, A., Sanchez-Cespedes, M., Gitt, A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4218 · Cited by 939
Self-citationFrom cells to organs: building polarized tissue
Bryant, D. M., & Mostov, K. E. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2523 · Cited by 786
Aigner, K., Dampier, B., Descovich, L., Mikula, M., Sultan, A., Schreiber, M., Mikulits, W., Brabletz, T., Strand, D., Obrist, P., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210508 · Cited by 617
Transcriptional regulation of cell polarity in EMT and cancer
Moreno-Bueno, G., Portillo, F., & Cano, A. (2008) · Oncogene · doi:10.1038/onc.2008.346 · Cited by 610
Toyota, M., Suzuki, H., Sasaki, Y., Maruyama, R., Imai, K., Shinomura, Y., & Tokino, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0325 · Cited by 600
The Transcriptional Repressor ZEB1 Promotes Metastasis and Loss of Cell Polarity in Cancer
Spaderna, S., Schmalhofer, O., Wahlbuhl, M., Dimmler, A., Bauer, K., Sultan, A., Hlubek, F., Jung, A., Strand, D., Eger, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5682 · Cited by 532
Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer
Pardali, K., & Moustakas, A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.06.004 · Cited by 526
Gibbons, D. L., Lin, W., Creighton, C. J., Rizvi, Z. H., Gregory, P. A., Goodall, G. J., Thilaganathan, N., Du, L., Zhang, Y., Pertsemlidis, A., et al. (2009) · Genes & Development · doi:10.1101/gad.1820209 · Cited by 512
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets
Baffa, R., Fassan, M., Volinia, S., O'Hara, B., Liu, C., Palazzo, J. P., Gardiman, M., Rugge, M., Gomella, L. G., Croce, C. M., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2586 · Cited by 473
Chaffer, C. L., Brennan, J. P., Slavin, J. L., Blick, T., Thompson, E. W., & Williams, E. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2044 · Cited by 455
Hurteau, G. J., Carlson, J. A., Spivack, S. D., & Brock, G. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1058 · Cited by 390
Coordinated epigenetic repression of the miR‐200 family and miR‐205 in invasive bladder cancer
Wiklund, E. D., Bramsen, J. B., Hulf, T., Dyrskjøt, L., Ramanathan, R., Hansen, T. B., Villadsen, S. B., Gao, S., Ostenfeld, M. S., Borre, M., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25461 · Cited by 367
MicroRNAs and cancer: An overview
Medina, P. P., & Slack, F. J. (2008) · Cell Cycle · doi:10.4161/cc.7.16.6453 · Cited by 340
Mesenchymal to Epithelial Transition in Development and Disease
Chaffer, C. L., Thompson, E. W., & Williams, E. D. (2007) · Cells Tissues Organs · doi:10.1159/000101298 · Cited by 324
miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases
Dykxhoorn, D. M., Wu, Y., Xie, H., Yu, F., Lal, A., Petrocca, F., Martinvalet, D., Song, E., Lim, B., & Lieberman, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007181 · Cited by 324
Ceppi, P., Mudduluru, G., Kumarswamy, R., Rapa, I., Scagliotti, G. V., Papotti, M., & Allgayer, H. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0052 · Cited by 303
DNA Methylation as a Therapeutic Target in Cancer
Issa, J.-P. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2076 · Cited by 301
Polarity proteins in migration and invasion
Etienne-Manneville, S. (2008) · Oncogene · doi:10.1038/onc.2008.347 · Cited by 295
Lin, T., Ponn, A., Hu, X., Law, B. K., & Lu, J. (2010) · Oncogene · doi:10.1038/onc.2010.234 · Cited by 291
Vrba, L., Jensen, T. J., Garbe, J. C., Heimark, R. L., Cress, A. E., Dickinson, S., Stampfer, M. R., & Futscher, B. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008697 · Cited by 285
Huang, Y.-W., Liu, J. C., Deatherage, D. E., Luo, J., Mutch, D. G., Goodfellow, P. J., Miller, D. S., & Huang, T. H.-M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1499 · Cited by 264
Eades, G., Yao, Y., Yang, M., Zhang, Y., Chumsri, S., & Zhou, Q. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.229401 · Cited by 263
Micro‐RNA signature of the epithelial–mesenchymal transition in endometrial carcinosarcoma
Castilla, M. Á., Moreno‐Bueno, G., Romero‐Pérez, L., De Vijver, K. V., Biscuola, M., López‐García, M. Á., Prat, J., Matías‐Guiu, X., Cano, A., Oliva, E., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2802 · Cited by 226
The morphological and molecular features of the epithelial-to-mesenchymal transition
Moreno-Bueno, G., Peinado, H., Molina, P., Olmeda, D., Cubillo, E., Santos, V., Palacios, J., Portillo, F., & Cano, A. (2009) · Nature Protocols · doi:10.1038/nprot.2009.152 · Cited by 221
Dumont, N., Wilson, M. B., Crawford, Y. G., Reynolds, P. A., Sigaroudinia, M., & Tlsty, T. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807146105 · Cited by 210
Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells
Neves, R., Scheel, C., Weinhold, S., Honisch, E., Iwaniuk, K. M., Trompeter, H.-I., Niederacher, D., Wernet, P., Santourlidis, S., & Uhrberg, M. (2010) · BMC Research Notes · doi:10.1186/1756-0500-3-219 · Cited by 178
miR-200b mediates post-transcriptional repression of ZFHX1B
Christoffersen, N. R., Silahtaroglu, A., Ørom, U. A., Kauppinen, S., & Lund, A. H. (2007) · RNA · doi:10.1261/rna.586807 · Cited by 175
Requirement of HDAC6 for Transforming Growth Factor-β1-induced Epithelial-Mesenchymal Transition
Shan, B., Yao, T.-P., Nguyen, H. T., Zhuo, Y., Levy, D. R., Klingsberg, R. C., Tao, H., Palmer, M. L., Holder, K. N., & Lasky, J. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802786200 · Cited by 172
Polarity protein alterations in carcinoma: a focus on emerging roles for polarity regulators
Huang, L., & Muthuswamy, S. K. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.12.001 · Cited by 144
Abell, A. N., Jordan, N. V., Huang, W., Prat, A., Midland, A. A., Johnson, N. L., Granger, D. A., Mieczkowski, P. A., Perou, C. M., Gomez, S. M., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.03.008 · Cited by 132
Epigenetic Cancer Therapy Makes Headway
Mack, G. S. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj447 · Cited by 110
Yang, X., Pursell, B. M., Lu, S., Chang, T.-K., & Mercurio, A. M. (2009) · Journal of Cell Science · doi:10.1242/jcs.049148 · Cited by 102
Fujimoto, K., Beauchamp, R. D., & Whitehead, R. H. (2002) · Gastroenterology · doi:10.1053/gast.2002.37065 · Cited by 93
Potential mRNA Degradation Targets of hsa-miR-200c
Hurteau, G. J., Spivack, S. D., & Brock, G. (2006) · Cell Cycle · doi:10.4161/cc.5.17.3133 · Cited by 82
Aokage, K., Ishii, G., Ohtaki, Y., Yamaguchi, Y., Hishida, T., Yoshida, J., Nishimura, M., Nagai, K., & Ochiai, A. (2010) · International Journal of Cancer · doi:10.1002/ijc.25500 · Cited by 60
Vantyghem, S. A., Allan, A. L., Postenka, C. O., Al‐Katib, W., Keeney, M., Tuck, A. B., & Chambers, A. F. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-0745-1 · Cited by 54
Chou, J.-L., Chen, L.-Y., Lai, H., & Chan, M. W. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.525353 · Cited by 43
microRNAs, RNA binding proteins and cancer
Agami, R. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02279.x · Cited by 41
Cited by
Non-coding RNAs in human disease
Esteller, M. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3074 · Cited by 4,825
Self-citationRegulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
The epigenetics of epithelial-mesenchymal plasticity in cancer
Tam, W. L., & Weinberg, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3336 · Cited by 1,163
Goodall, G. J., & Wickramasinghe, V. O. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00306-0 · Cited by 1,066
Regulatory Mechanism of MicroRNA Expression in Cancer
Ali Syeda, Z., Langden, S. S. S., Munkhzul, C., Lee, M., & Song, S. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051723 · Cited by 995
Metadata
- Authors
- Davalos, V, Moutinho, C., Villanueva, A., Boque, R., Silva, P., Carneiro, F., & Esteller, M.
- Venue
- Oncogene
- Published
- 2011-08-29
- Volume
- 31
- Issue
- 16
- Pages
- 2062-2074
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2048910343
- Cited by
- 351
- References
- 61
- FWCI
- 10.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.